The Manager of Communications is responsible for implementing a proactive and responsive communications strategy that positions the Alliance as the leader in TB drug development with a compelling mission, and a credible support-worthy partner. This strategy must be effective for multiple audience including industry, public sector researchers, philanthropic and private donors, policy makers and government donors, global health advocates, TB experts, prospective employees, physicians and patients.
The objective of the Communications function is to enable the achievement of TB Alliance’s long term goals which includes broadening the base of financial support for the mission, increasing our international leadership position in TB Drug Development.
As a member of a two person team, the Manager of Communications will be the primary internal writer and content developer, and responsible for tactical implementation of various communications strategies. The Manager, Communications will participate in all aspects of communications including media and public relations, publications development and disseminations, web-based communications, vendor relations, and communications-related administrative matters.
Provide internal communications counsel to:
Raise TB awareness and expand the positive image of the Alliance through:
The TB Alliance is an international product development partnership (PDP) created to accelerate the development and adoption of urgently needed new anti-tuberculosis (TB) drugs. As a not-for-profit organization, the TB Alliance functions through strategic relationships with pharmaceutical companies, academic institutions, research labs, and governmental agencies, and deploys preferred service providers for contract research. Based in New York City, the TB Alliance also operates a satellite office in Pretoria, South Africa.
The TB Alliance is preeminent in the TB drug development field and is pursuing faster, simpler treatments for all forms of TB through the innovative PDP business model that bridges the expertise and functionality of industry with academic and public sector interests to meet a major unmet global health need.
With an annual operating budget of approximately $60 million, the TB Alliance leads the advancement of the most comprehensive R&D portfolio of TB drug candidates in history. Currently, a portfolio of more than 20 projects spans from target validation to Phase III clinical development. Additionally, the TB Alliance drives efforts to ensure regulatory approval, country adoption of new regimens, and widespread availability of new drug regimens to patients.
Tuberculosis kills nearly 1.5 million each year. Yet, current treatments are antiquated, inadequate, and excessively burdensome. Long, demanding treatment schedules prove too much for many patients, leading to the emergence of multi- and extensively- drug-resistant TB (MDR-TB and XDR-TB), which are exponentially more expensive and difficult to treat.
To apply for this position, send resumes and cover letters to firstname.lastname@example.org. Please include “Manager, Communications” in the subject line.